Insights
FDA Approves Combination NSAID/Opioid Seglentis
2 MIN READ
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
FDA Approves Combination NSAID/Opioid Seglentis
2 MIN READ
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA). Seglentis contains tramadol, a short-acting opioid, and celecoxib, a non-steroidal anti-inflammatory drug (NSAID), and is indicated for adults in the management of acute pain that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Specialty Services Are a Big Deal
1 MIN READ
When adjusters have to jump through hoops to make referrals, they lose precious time. When it comes to specialty services, we have your back.
Navigating Michigan’s No-Fault Auto Fee Schedule Four Months In
On-Demand
In this upcoming webinar, hear the latest from Enlyte experts on Michigan’s no-fault fee schedule, including product info and regulatory changes.
2021 mPower Virtual Conference
On-Demand
The Mitchell | Genex | Coventry team looks forward to connecting with you at the 2021 mPower Conference, taking place virtually October 12–14, 2021.
From Permanent Disability to Full-Duty Success
2 MIN READ
Disability Case Management Meet Nancy LeBlanc, RN, CCM, CPDM, WES
WorkCompWire: 6 Ways to Ensure Your Program Crafts Quality IME Cover Letters
1 MIN READ
By Richard Leonardo, Senior VP of IME and Specialty Services, Genex Services